Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava.

ABSTRACT:

Background

Tobacco use is the leading cause of many preventable diseases, resulting in premature death or disease. Given that the majority of adult who smoke want to stop, this health burden could be significantly reduced if the success rate of tobacco cessation can be improved. In addition, most adults planning to quit were interested in trying complementary approaches to facilitating tobacco cessation, which is currently lacking. Therefore, there is an unmet and urgent need for novel interventions to improve the success of tobacco cessation. If such an intervention can reduce tobacco-associated lung carcinogenesis, that will be more desirable. The goal of this project is to develop a safe and effective kava-based intervention to enable tobacco cessation and reduce lung cancer ris

SUBMITTER: Xing C 

PROVIDER: S-EPMC9847434 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature